Bioactivity | Bamadutide (SAR425899) is a potent dual glucagon-like peptide-1 receptor/glucagon receptor agonist. Bamadutide (SAR425899) improves postprandial glucose control by significantly enhancing β-cell function and slowing glucose absorption rate in vivo. Bamadutide (SAR425899)can be used for type 2 diabetes research[1]. |
Name | Bamadutide |
CAS | 1596343-09-7 |
Sequence | His-(D-Ser)-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-{N6-(N-(1-oxohexadecyl)-Ggu)-Lys}-Glu-Ser-Lys-Ala-Ala-Gln-Asp-Phe-Ile-Glu-Trp-Leu-Lys-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
Shortening | H-{D-Ser}-QGTFTSDLSKQKES-{N6-(N-(1-oxohexadecyl)-Ggu)-Lys}-AAQDFIEWLKAGGPSSGAPPPS-NH2 |
Formula | C200H313N51O63 |
Molar Mass | 4439.92 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Olof Eriksson, et al.Imaging of the Glucagon Receptor in Subjects with Type 2 Diabetes.J Nucl Med.2021 Jun 1;62(6):833-838. |